(Press-News.org) PITTSBURGH, May 17, 2021 - Monoclonal antibodies, a COVID-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60% in those most likely to suffer complications of the disease, according to an analysis of UPMC patients who received the medication compared to similar patients who did not.
UPMC and University of Pittsburgh School of Medicine physician-scientists published the findings today in Open Forum Infectious Diseases, a journal of the Infectious Diseases Society of America. The study involved bamlanivimab, a monoclonal antibody that is now offered only in combination with another monoclonal antibody to further increase its effectiveness--a change mandated by the federal government after the study's completion.
"The fact that we found bamlanivimab to be this effective in keeping our patients with COVID-19 out of the hospital bodes very well for the future use of the currently available monoclonal therapies, something we are studying now," said lead author Ryan Bariola, M.D., associate professor in Pitt's Division of Infectious Diseases and director of the UPMC Community Hospital Antimicrobial Stewardship Efforts (CHASE) Program. "If given early to high-risk patients, this treatment works to prevent COVID-19-related complications. We look forward to research with next-generation monoclonal antibodies and hope to continue to find safe and effective treatments for our patients."
Monoclonal antibodies are a type of medication that seeks out the COVID-19 virus in a person's body and blocks it from infecting their cells and replicating. Currently, the U.S. Food & Drug Administration has granted Emergency Use Authorization to two monoclonal antibody treatments, which are given through a one-time IV infusion. This is the same type of emergency authorization given to the COVID-19 vaccines being administered in the U.S.
Federal and UPMC guidelines require the antibodies be administered within 10 days of COVID-19 symptom onset and diagnosis for patients at high risk of a poor outcome, including patients of advanced age, who are obese or those with conditions such as diabetes or lung disease.
UPMC has given monoclonal antibody infusions to 2,600 qualifying patients. The researchers analyzed data on the first 232 patients treated with bamlanivimab to learn how they've fared since their infusions. They compared antibody-treated patients' data to that of a matched set of patients of similar age and health status who had contracted COVID-19 and were eligible for the treatment but did not receive it.
The strongest effect was seen in older patients. Those age 65 and older who received monoclonal antibodies from UPMC were nearly three times less likely to be hospitalized or die in the following month, compared to their untreated counterparts. The results were less pronounced in younger populations, but overall, more positive results were seen in those who received monoclonal antibody infusions than in those who did not.
UPMC's data also showed a stronger positive effect the earlier patients received the treatment after contracting the virus, and a very low rate of adverse reactions to the infusion, all of which were mild.
"If there's one key take-away that we're seeing in our data, it's this: If you get COVID-19 and are at higher risk for severe illness, ask your doctor about monoclonal antibodies," said Graham Snyder, M.D., M.S., medical director of infection prevention and hospital epidemiology at UPMC and associate professor in Pitt's School of Medicine. "Don't hesitate. Early treatment, while your symptoms are still mild, may be essential."
INFORMATION:
UPMC offers monoclonal antibody infusions at 18 dedicated infusion sites in Pennsylvania, Maryland and New York, as well as in Emergency Departments, behavioral health centers and patients' homes. Patients and providers can find out more about monoclonal antibody treatment at UPMC by visiting upmc.com/AntibodyTreatment or calling 866-804-5251.
Additional authors on this paper are Erin McCreary, Pharm.D., Richard J. Wadas, M.D., Kevin E. Kip, Ph.D., Oscar C. Marroquin, M.D., Tami Minnier, M.S.N., R.N., Stephen Koscumb, Kevin Collins, Mark Schmidhofer, M.D., Judith A. Shovel, R.N., Mary Kay Wisniewski, M.T., M.A., Colleen Sullivan, M.H.A., Donald M. Yealy, M.D., David A. Nace, M.D., M.P.H., David T. Huang, M.D., M.P.H., Ghady Haidar, M.D., Tina Khadem, Pharm.D., Kelsey Linstrum, M.A.S., Christopher W. Seymour, M.D., M.Sc., Stephanie K. Montgomery, M.S., and Derek C. Angus, M.D., M.P.H., all of Pitt and UPMC.
About UPMC
A $23 billion health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. The largest nongovernmental employer in Pennsylvania, UPMC integrates 92,000 employees, 40 hospitals, 700 doctors' offices and outpatient sites, and a 4 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. In the most recent fiscal year, UPMC contributed $1.4 billion in benefits to its communities, including more care to the region's most vulnerable citizens than any other health care institution, and paid more than $800 million in federal, state, and local taxes. Working in close collaboration with the University of Pittsburgh Schools of the Health Sciences, UPMC shares its clinical, managerial, and technological skills worldwide through its innovation and commercialization arm, UPMC Enterprises, and through UPMC International. U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside among the nation's best hospitals in many specialties and ranks UPMC Children's Hospital of Pittsburgh on its Honor Roll of America's Best Children's Hospitals. For more information, go to UPMC.com.??? ??????
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu.
http://www.upmc.com/media
Contact: Allison Hydzik
Office: 412-647-9975
Mobile: 412-559-2431
E-mail: HydzikAM@upmc.edu
Contact: Danielle Sampsell
Office: 814-889-2622
Mobile: 412-420-9818
E-mail: SampsellD@upmc.edu
Cultural diversity -- indicated by linguistic diversity -- and biodiversity are linked, and their connection may be another way to preserve both natural environments and Indigenous populations in Africa and perhaps worldwide, according to an international team of researchers.
"The punchline is, that if you are interested in conserving biological diversity, excluding the Indigenous people who likely helped create that diversity in the first place may be a really bad idea," said Larry Gorenflo, professor of landscape architecture, geography and African studies, Penn State. "Humans are part of ecosystems and I hope this study will usher in a more committed effort to engage Indigenous people in conserving localities containing key biodiversity."
Gorenflo, ...
Indigenous people have lived in the Bears Ears region of southeastern Utah for millennia. Ancestral Pueblos built elaborate houses, check dams, agricultural terraces and other modifications of the landscape, leaving ecological legacies that persist to this day. Identifying how humans interacted with past environments is critical for informing how best to protect archaeological sites and ecological diversity in the present. This "archaeo-ecosystem" approach would facilitate co-management of public lands in ways that promote Indigenous health, cultural reclamation and sovereignty.
For the first time, a new study evaluated ecological legacies, archaeo-ecosystem restoration and Indigenous ...
There are roughly 50 billion individual birds in the world, a new big data study by UNSW Sydney suggests - about six birds for every human on the planet.
The study - which bases its findings on citizen science observations and detailed algorithms - estimates how many birds belong to 9700 different bird species, including flightless birds like emus and penguins.
It found many iconic Australian birds are numbered in the millions, like the Rainbow Lorikeet (19 million), Sulphur-crested Cockatoo (10 million) and Laughing Kookaburra (3.4 million). But other natives, like the rare Black-breasted Buttonquail, only have around 100 members left.
The findings are being published this week in the Proceedings ...
Scientists studying the impact of record heat and drought on intact African tropical rainforests were surprised by how resilient they were to the extreme conditions during the last major El Niño event.
The international study, reported in Proceedings of the National Academy of Sciences today, found that intact rainforests across tropical Africa continued to remove carbon from the atmosphere before and during the 2015-2016 El Niño, despite the extreme heat and drought.
Tracking trees in 100 different tropical rainforests across six African countries, the researchers found that intact forests across the continent still removed 1.1 billion tonnes of carbon dioxide per year from the atmosphere during the El Niño monitoring ...
Researchers at Baylor College of Medicine have followed the progression of breast cancer in an animal model and discovered a path that transforms a slow-growing type of cancer known as estrogen receptor (ER)+/HER2+ into a fast-growing ER-/HER2+ type that aggressively spreads or metastasizes to other organs.
The study, which appears in the Proceedings of the National Academy of Sciences, has implications for breast cancer therapy as it suggests the need to differentiate cancer subtypes according to the path the cells follow. Different paths might be linked to different cancer behavior, which should be taken into consideration to plan treatment appropriately.
"In ...
Scientists have detected new early-warning signals indicating that the central-western part of the Greenland Ice Sheet may undergo a critical transition relatively soon. Because of rising temperatures, a new study by researchers from Germany and Norway shows, the destabilization of the ice sheet has begun and the process of melting may escalate already at limited warming levels. A tipping of the ice sheet would substantially increase long-term global sea level rise.
"We have found evidence that the central-western part of the Greenland ice sheet has been destabilizing and is now close to a critical transition," explains lead author Niklas ...
A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold the solution to better delivery of Covid-related therapies directly to the lungs.
Scientists at the University of Zurich have modified a common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics directly into tumor cells. Unlike chemotherapy or radiotherapy, this approach does no harm to normal healthy cells. Once inside tumor cells, the delivered genes serve as a blueprint for therapeutic ...
When doctors or scientists want to peer into living tissue, there's always a trade-off between how deep they can probe and how clear a picture they can get.
With light microscopes, researchers can see submicron-resolution structures inside cells or tissue, but only as deep as the millimeter or so that light can penetrate without scattering. Magnetic resonance imaging (MRI) uses radio frequencies that can reach everywhere in the body, but the technique provides low resolution -- about a millimeter, or 1,000 times worse than light.
A University of California, Berkeley, researcher has now shown that microscopic ...
PHILADELPHIA and MELBOURNE, Australia -- (May. 17, 2021) -- A team of scientists from The Wistar Institute in Philadelphia and the Peter MacCallum Cancer Center in Melbourne, Australia, discovered a new checkpoint mechanism that fine-tunes gene transcription. As reported in a study published in Cell, a component of the Integrator protein complex tethers the protein phosphatase 2A (PP2A) to the site of transcription allowing it to stop the activity of the RNA polymerase II enzyme (RNAPII). Disruption of this mechanism leads to unrestricted gene transcription and is implicated in cancer.
The study points to new viable opportunities for therapeutic ...
Exposure to light is compulsory for photosynthetic organisms for the conversion of inorganic compounds into organic ones. However, if there is too much solar energy, the photosystems and other cell components could be damaged. Thanks to special protective proteins, the overexcitation is converted into heat - in the process called non-photochemical quenching. The object of the published study, OCP, was one of such defenders. It was first isolated in 1981 from representatives of the ancient group of photosynthetic bacteria, ?yanobacteria. OCP comprises two domains forming a cavity, in which a carotenoid pigment is embedded.
"When light is absorbed by the carotenoid molecule, OCP can change from an inactive orange to an active red form. ...
